ReviewPharmacology & therapeutics2022

Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.

John A McClung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.